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Abstract
Background
Since 1982, HIV-1 epidemics have evolved to different scenarios in terms of transmission
routes, subtype distribution and characteristics of transmission clusters. We investigated
the evolutionary history of HIV-1 subtype B in south Spain.
Patients & Methods
We studied all newly diagnosed HIV-1 subtype B patients in East Andalusia during the
2005–2012 period. For the analysis, we used the reverse transcriptase and protease
sequences from baseline resistance, and the Trugene® HIV Genotyping kit (Siemens,
Barcelona, Spain). Subtyping was done with REGA v3.0. The maximum likelihood trees
constructed with RAxML were used to study HIV-1 clustering. Phylogeographic and phylo-
dynamic profiles were studied by Bayesian inference methods with BEAST v1.7.5 and
SPREAD v1.0.6.
Results
Of the 493 patients infected with HIV-1 subtype B, 234 grouped into 55 clusters, most of
which were small (44 clusters 5 patients, 31 with 2 patients, 13 with 3). The rest (133/234)
were grouped into 11 clusters with 5 patients, and most (82%, 109/133) were men who
have sex with men (MSM) grouped into 8 clusters. The association with clusters was more
frequent in Spanish (p = 0.02) men (p< 0.001), MSM (p<0.001) younger than 35 years (p =
0.001) and with a CD4+ T-cell count above 350 cells/ul (p<0.001). We estimated the date of
HIV-1 subtype B regional epidemic diversification around 1970 (95% CI: 1965–1987), with
an evolutionary rate of 2.4 (95%CI: 1.7–3.1) x 10−3 substitutions/site/year. Most clusters
originated in the 1990s in MSMs. We observed exponential subtype B HIV-1 growth in
1980–1990 and 2005–2008. The most significant migration routes for subtype B went from
inland cities to seaside locations.
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Conclusions
We provide the first data on the phylodynamic and phylogeographic profiles of HIV-1 sub-
type B in south Spain. Our findings of transmission clustering among MSMs should alert
healthcare managers to enhance preventive measures in this risk group in order to prevent
future outbreaks.
1. Introduction
Human immunodeficiency virus type 1 (HIV-1) is characterised by high genetic variability
caused by its high rate of nucleotide substitution [1,2] and recombination capacity [3], which
has led to a wide diversity of subtypes and recombinant forms. HIV-1 subtype B is the most
prevalent of these variants in central and western Europe [4,5], where it is responsible for
almost 70% of new infections [6].
Although the epidemic tends to be stabilising in certain populations [7], in some sub-epi-
demics, especially in men who have sex with men (MSM), HIV-1 is transmitted more effi-
ciently than in other risk groups [8–11].
Since HIV-1 was identified in the early 1980s [12], molecular epidemiology has helped dis-
cover certain aspects of the virus, and has been key in understanding the virus heterogeneity
and prevalence of subtypes, and in studying the transmission of drug resistance to antiretrovi-
ral drugs [13–17]. Through the phylogenetic relation between viral nucleic acid sequences,
phylogenetic analyses can be informative of transmission events between risk groups [18].
Phylodynamics and phylogeography can also help provide data on the evolutionary history of
a certain viral population. So they can be used to study the epidemic trends, and the temporal
[19–23] and spatial [24–27] dynamics, of this virus.
East Andalusia is located in south Spain, and includes the provinces of Jae´n, Almerı´a, and
Granada. Tourism and migration in this area have contributed to a wide diversity of HIV-1
viral subtypes, but subtype B is still the most prevalent [28]. Our laboratory is the reference
centre for studying antiretroviral drug resistance in this area, and we update a database that
links clinical data to virological data. As we have access to the pol sequences in all the newly
diagnosed patients in this area, we attempted to study the evolutionary history of the HIV-1
subtype B in east Andalusia, and the existence of long-term HIV-1 lineages, by using molecular
epidemiology tools. We analysed which groups were at increased risk of infection, the dynam-
ics of viral growth and its spread during the 2005–2012 period.
2. Methods
2.1 Study population
The analysis included sequences generated from the earliest sample available before ART-initi-
ation (baseline), from all the medical centres that attend HIV-1-infected individuals in east
Andalusia, during the 2005–2012 period. The study population included all newly diagnosed
HIV-seropositives irrespective of their HIV-infection status (chronic or recent). Of the 693
patients infected with HIV-1 from the provinces of Granada (capital city and Motril), Jae´n,
and Almerı´a (capital city and El Ejido), 493 (71%) were patients infected with HIV-1 subtype
B. Partial pol gene sequences (protease (PR), codons 4–99; reverse transcriptase (RT), codons
38–247) were available and linked to demographic (risk group, age, sex, country of origin
and attending hospital of origin), clinical (CD4+ T-cell count) and virological (viral load)
information.
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2.2 HIV-1 pol sequencing and subtype assignment
Protease and reverse transcriptase sequences were obtained with the Trugene1 HIV Geno-
typing kit (Siemens, Barcelona, Spain). The viral subtype was studied with the REGA v3.0
subtyping tool (found at http://dbpartners.stanford.edu:8080/RegaSubtyping/stanford-hiv/
typingtool/) and was confirmed by a phylogenetic analysis. A representative data set of the
pure subtypes and recombinant forms of HIV-1 group M (A-K + recombinants) sequences
from the Los Alamos HIV sequence database (http://www.hiv.lanl.gov) was used as reference.
2.3. Phylogenetic Analysis
All the sequences were edited manually and aligned using ClustalW [31]. The best-fit model of
nucleotide substitution for the analysis was obtained through FindModel (accessible at http://
www.hiv.lanl.gov/content/sequence/findmodel/findmodel.html). A preliminary analysis was
performed using maximum likelihood (ML) (randomised Accelerated Maximum Likelihood,
RAxML), accessible through the CIPRES science Gateway [32]. We used the best-fit model
selected by FindModel: general time-reversible (GTR) with gamma-distributed rate heteroge-
neity across sites model and 1,000 bootstrap iterations for this analysis. The associations
between the sequences with related nodes were studied, where a 70% bootstrap value was
taken as a significantly reliable value [33]. However, we confirmed these lineages by the Bayes-
ian approach described below. We analysed the subtype B lineages of greater epidemiological
relevance in detail (five or more related sequences).
2.4 Statistical analyses and clustering predictors
A logistic regression analysis was run to assess the associations among the clustering and clini-
cal, demographic or virological characteristics. Statistical analyses were carried out with SPSS
15 (SPSS Inc., Chicago, IL, USA).
2.5 Reconstruction of evolutionary and demographic history
The Bayesian Markov Chain Monte Carlo (MCMC) approach was applied to this data set, as
implemented in BEAST v1.7.5 [34,35]. To improve the convergence of chains and molecular
clock precision, the BEAST analysis was applied to a large set of the east Andalusian HIV-1
sequences (n = 419). A time scale in phylogenetic trees was set using the Shapiro-Rambaut-
Drummond-2006 (SRD06) nucleotide substitution model, which adapts the Hasegawa,
Kishino, and Yano (HKY) nucleotide substitution model by applying two partitions according
to the nucleotide codon (first/second and third). We estimated the evolutionary rate (μ, nucle-
otide substitutions per site per year, subst./site/year) by a previous analysis with 200 HIV-1
subtype B sequences from the viruses collected during 27 years, which were retrieved from the
Los Alamos HIV sequence database. These data were used to adjust a lognormal prior distribu-
tion for the clock rate (ucld.mean parameter; mean = 0.0024, stdev = 0.25).
We used a relaxed uncorrelated lognormal clock (UCLN) [36] and a demographic nonpara-
metric model, Bayesian Skyline Plot (BSP) [37]. The MCMC was run for 250 million states by
sampling every 50,000. We estimated the evolutionary rate (μ, nucleotide substitutions per site
Phylogenetic Profiles of Subtype B HIV-1 in South Spain
PLOS ONE | DOI:10.1371/journal.pone.0168099 December 21, 2016 3 / 17
per year, subst./site/year) and the time and location of the most recent common ancestor
(MRCA) of the different HIV-1 clades. For this analysis, we employed TRACER v1.6 (accessi-
ble at http://tree.bio.ed.ac.uk/software/tracer/). Only traces with an effective sample size (ESS)
of> 200 were accepted after excluding an initial 10%. The BSP model allowed us to estimate
effective changes in population size (Ne), and to run a demographic analysis in TRACER v1.6.
To estimate the ancestral localisation of the virus and the most significant epidemiological
links, we followed a discrete asymmetric Bayesian phylogeographic approach by means of
Bayesian Stochastic Search Variable Selection (BSSVS), and by georeferencing each sequence
with discrete latitude and longitude data. We used SPREAD V1.0.6 (available at http://www.
kuleuven.ac.be/aidslab/phylogeography/SPREAD.html.) and Bayes factor sets to identify well-
supported rates and to summarise the geographic spread and the most significant epidemio-
logical links of HIV-1 subtype B dispersal in east Andalusia. All the trees were visualised and
edited with FigTree, v 1.4.0 (available at http://tree.bio.ed.ac.uk/software/figtree). In these
trees, the clusters of more epidemiologic relevance, as previously defined by ML, and with a
posterior probability above 0.9 (PP>0.9), were studied.
3. Results
The phylogenetic analyses through ML (Fig 1) showed 55 clusters, which represented 47%
(n = 234) of our population: 43% (101/234) of the patients grouped into 44 small clusters: 31
clusters of two patients [13 MSM, 12 heterosexual (HTX), and six intravenous drug users
(IVDU)]; 13 clusters of three patients, (MSM = 7, HTX = 5 and IVDU = 1). All the other
patients (57% (133/234)) were grouped into 11 clusters of five subjects or more. Their demo-
graphic, clinical and virological characteristics are offered in Table 1. We found 11 clusters of a
larger size (5), eight formed by MSM and three by IVDU. It was noteworthy that one cluster
was formed by 58 young subjects (median age of 33) with a median CD4+ T-cell count of 518
cells/μl. This cluster showed short branches in the ML tree (Fig 1), which indicated short times
between infections.
Table 2 shows the demographic characteristics of the patients, who were included, or not,
in the transmission clusters. Statistically significant differences were observed between the
patients included, or not, in the clusters. The association was more frequent in Spanish
(p = 0.02) men (p< 0.001), MSM (p<0.001), younger than 35 years (p = 0.001) and with a
CD4+ T-cell count above 350 cells/ul (p<0.001).
In order to test the integrity of clusters, we retrieved from GenBank the five most closely
related (at least 95% of genetic similarity) HIV-1 sequences to all the 234 study sequences
included in the clusters using ViroBLAST (https://indra.mullins.microbiol.washington.edu/
viroblast/viroblast.php). In a phylogenetic tree constructed with RAxML, we confirmed that
none of the initially found clusters were broken down by adding these similar sequences from
public databases, which ensures their status of real clusters circulating in east Andalusia (S1
Fig). It was noteworthy that sporadic GenBank sequences (particularly from other Spanish
regions, but with limited available demographic information) formed part of some of east
Andalusian lineages, which suggests linkage to other epidemics.
By analysing the PR+RT genomic region, with an uncorrelated lognormal clock and using
the Bayesian Skyline Plot model, we obtained a mean evolutionary rate of 2.4 (95% credible
region: 1.7–3.1) x 10−3 substitutions/site/year. The MRCA for subtype B in east Andalusia was
estimated in 1970 (95%CI: 1965–1987). The Bayesian Maximum clade credibility (MCC) tree
(Fig 2) shows the clusters in a temporal context. The inferred tMRCA and ancestral location
posterior probabilities (>0.9 in all cases) for clusters are shown in Table 1. The tree repre-
sented in Fig 3 indicates the subtype B phylogeography in east Andalusia, while the most
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probable ancestor location and location probability of the most relevant clusters are provided
in Table 1.
The oldest lineages found in east Andalusia originated in the late 1970s and the early 1980s
in the coastal area of Motril, and were formed by intravenous drug users: Cluster I (location
probability = 0.64) in 1979 (95%CI: 1976–1991) and Cluster II (location probability = 0.94) in
1984 (95%CI: 1979–1994). As shown in Table 1, most of the more epidemiologically relevant
clusters were formed by MSMs, most of which originated in the 1990s, all in Granada, with
location probabilities > 0.9.
The Bayesian phylogeographic analyses of HIV-1 subtype B indicated that the ancestral lin-
eages originated in Granada. From this city, the HIV-1 subtype B epidemic in Andalusia
Fig 1. ML phylogenetic tree of the global HIV-1 subtype B pol sequences. The phylogenetic tree was constructed by the general time-reversible with
gamma-distributed rate heterogeneity across sites model of substitution implemented into RAxML. Branches are drawn on scale with the bar at the bottom,
which represents 0.03 nucleotide substitution per site and a progressive bootstrap gradient value using FigTree, v. 1.4. The statistically highly supported
nodes (bootstrap >70%) and the clusters with five or more related sequences are indicated by an asterisk (*).
doi:10.1371/journal.pone.0168099.g001
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sequentially propagated to different peripheral areas of east Andalusia, such as the coasts of El
Ejido, Motril and Almerı´a, and eventually to the landlocked area of Jae´n. The most significant
(Bayes Factor>3) migration routes of HIV-1 subtype B showed directionality from the inland
Granada and Jae´n regions to the coastal areas of El Ejido and Almerı´a (Fig 4).
Table 2. Clinical, demographic and virological characteristics of the patients within or outside of transmission clusters obtained by phylogenetic
analyses.
Patients, n (%)
Total Inside Cluster Outside Cluster P valuea OR (95% CI) P valueb
493(100) 234(100) 259(100)
Gender <0.001
Male 404 (81.9) 209(89.3) 195(75.3) Ref
Female 89 (18.1) 25(10.7) 64(24.7) 0.312(0.184–0.531) <0.001
Nationality (453)* 0.020
Spanish 398 (87.9) 196 (89.9) 202 (86) Ref
Foreign 55 (12.1) 22 (10.1) 33 (14) 0.491(0.267–0.904) 0.022
Age (460)* 0.001
<35 123(26.7) 78(35.3) 45(18.8) Ref
35–45 167(36.3) 72(32.6) 95(39.7) 0.480(0.299–0.771) 0.002
>45 170(37) 71(32.1) 99(41.4) 0.445(0.278–0.774) 0.001
City 0.082
Almerı´a 60(12.2) 26(11.1) 34(13.1)
El Ejido 66(13.4) 31(13.2) 35(13.5)
Granada 233(47.3) 112(47.9) 121(46.7)
Motril 46(9.3) 30(12.8) 16(6.2)
Jae´n 88(17.8) 35(15) 53(20.5)
Sampling Year 0.388
2005 40(8.1) 16(6.8) 24(9.3)
2006 41(8.3) 14(6) 27(10.4)
2007 62(12.6) 29(12.4) 33(12.7)
2008 48(9.7) 26(11.1) 22(8.5)
2009 109(22.1) 58(24.8) 51(19.7)
2010 45(9.1) 26(11.1) 19(7.3)
2011 76(15.4) 30(12.8) 46(17.8)
2012 72(14.6) 35(15) 37(14.3)
Viral Load (456)* 0.070
<10.000 94(20.6) 38(17.4) 56(23.5)
10.000–100.000 205(45) 101(46.3) 104(43.7)
>100.000 157(34.4) 79(36.2) 78(32.8)
CD4 + T-cell count (427)* <0.001
<200 121(28.3) 38(19.2) 83(36.2) Ref
201–350 95(22.2) 43(21.7) 52(22.7) 2.079(1.185–3.646) 0.011
>350 211(49.4) 117(59) 94(41) 2.980(1.847–4.809) <0.001
Risk factor (433)* <0.001
MSM 210(48.5) 156(66.7) 54(27.1) Ref
IVDU 91(21) 39(16.7) 52(26.1) 0.286(0.170–0.480) <0.001
HTX 132(30.5) 39(16.7) 93(46.7) 0.271(0.170–0.432) <0.001
aP value for the chi-square test.
bP value for the univariate logistic regression.
*Data available for the number of patients indicated.
doi:10.1371/journal.pone.0168099.t002
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Fig 2. Maximum clade credibility tree generated by the Bayesian inference method using the BSP
non-parametric model, as implemented in BEAST v1.7.5. Branches were drawn using a progressive
posterior probability value of 0–1. The clusters previously defined through ML and the statistically highly
supported nodes (pp >0.9) were defined on a time scale.
doi:10.1371/journal.pone.0168099.g002
Fig 3. Bayesian maximum clade credibility phylogeographic tree of the HIV-1 Subtype B by the Bayesian discrete approach in BEAST v1.7.5.
The upper left bar represents the gradient of location probability. Nodes were drawn using a progressive ancestral probability location value of 0–1.
Colours of terminal and internal branches indicate the sampling location for each sequence and the most probable ancestral location for each clade,
respectively. The clusters of greatest epidemiological interest (5 patients grouped) are indicated by an asterisk (*).
doi:10.1371/journal.pone.0168099.g003
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A Bayesian Skyline plot (Fig 5) was used to illustrate the dynamic growth of HIV-1 subtype
B, and changes in the effective size of the epidemic in the last three decades were estimated. A
demographic analysis of our population showed initial growth in the 1980s, which stabilised in
the 1990s. In the first decade of this century, epidemic size became smaller, but once again
increased during the 2005–2008 period to finally stabilise. Finally, we analysed the phylody-
namic profiles of the major HIV-1 clade (Cluster VI) in east Andalusia (Fig 6). The exponential
Fig 4. The most significant epidemiological links of HIV-1 subtype B dispersal in Andalusia. Only the epidemiological links supported by Bayes
factor rates above 3 are indicated. The legend for the strength of the Bayes factor rates is shown on the upper right.
doi:10.1371/journal.pone.0168099.g004
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growth from 2005 may partially explain the increase in the effective population size of the epi-
demic HIV-1 subtype B during this period.
4. Discussion
More than half the HIV-1 subtype B-infected newly diagnosed patients in east Andalusia clus-
ter in transmission cluster formed by five or more individuals. Most patients are young MSM
with a high CD4+ T-cell count. These data suggest that a considerable number of patients pres-
ent acute and recent HIV-1 infection.
The estimated mean evolutionary rate of subtype B epidemics (2.4 (95%CI: 1.7–3.1) x 10−3
substitutions/site/year) was similar to that reported in other studies (1-3x10-3 substitutions/
site/year) [38–40]. This rate tended to be higher for the lineages formed largely by MSMs and
IVDUs, which suggests greater transmission efficiency and faster subtype B evolution in the
groups at risk of HIV-1 infection [41].
Our study, like other European surveys, [39, 42–44] confirmed that the subtype B epidemic
in east Andalusia started by diversifying before the first AIDS diagnosis was made in Spain in
1981 [45]. As in other studies of this kind, the dates estimated with phylodynamics approaches
that were sensitive to old lineages disappeared before our sampling times or past large waves of
new HIV-1 introductions. In addition, this diversification might have started elsewhere.
We demonstrated how the effective population size of subtype B HIV-1 in east Andalusia
underwent exponential growth from the early 1980s to the early 1990s, which is in line with
Fig 5. Demographic history of HIV-1 Subtype B in Andalusia. A demographic analysis was performed using the Bayesian Skyline Plot. The vertical
axes represent the estimated effective population size on a logarithmic scale. The black line represents the median estimated for the effective population
size with time. The blue area depicts the 95% HPD (high posterior density) confidence interval for this estimate.
doi:10.1371/journal.pone.0168099.g005
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reports from other countries [43, 46–49]. Our study suggests that the early East Andalusian
lineages originated in the 1980s among intravenous drug users in coastal areas. Epidemic
growth stabilised in the early 1990s (Fig 6), when prevention measures were first implemented
in Spain [50]. Since then, the transmission pattern in Spain has gradually evolved from IVDUs
to MSMs [45]. This partially explains why we detected an emergence of clustering among the
MSMs for these dates, which fell in line with increased high-risk behaviour by MSMs reported
in Europe for these years [51–53]. From this period, access to highly active antiretroviral treat-
ment (HAART) in 1996 in Spain has helped reduce the effective population size for HIV-1
among infected patients [54–57]. However from 2005, the subtype B epidemic in east Andalu-
sia underwent new exponential growth, which indicates that dedicated preventive measures to
avoid growth must be implemented and maintained. Multiple studies [19] have interpreted
the timing of changes in phylodynamic patterns in the context of other changes. Hence we
believe that this type of studies may serve as a tool to implement preventive strategies.
An especially important lineage in our population was cluster VI, which was formed by 58
individuals with MRCA, and appeared in 1994 (95%CI: 1987–1999). New subjects continued
to enter this cluster until the end of our study period. Indeed young MSM, with high CD4+ T-
cell counts at the time of diagnosis, made up this cluster, which suggests recent infection.
Our phylogeographic study showed how HIV-1 subtype B spread mainly from inland
regions to coastal cities, and from El Ejido to the city of Almerı´a in east Andalusia. This was
perhaps motivated primarily by a higher proportion of patients infected with HIV-1 to these
Fig 6. Demographic history of the major HIV-1 clade. A demographic analysis was performed using the Bayesian Skyline Plot. The vertical axes
represent the estimated effective population size on a logarithmic scale. The black line represents the median estimated for the effective population size
with time. The blue area depicts the 95% HPD (high posterior density) confidence interval for this estimate.
doi:10.1371/journal.pone.0168099.g006
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areas while visiting coastal areas and, secondly, also by many migrants (25/55, 45%) who con-
centrate in El Ejido, where approximately a third of patients are migrants (25/66, 38%; S2 Fig)
who come mainly from North Africa (15/25, 60%) (data not shown). For a number of years,
this area has been a gateway to African migration into Spain and Europe, and has contributed
to numerous transmission events.
Despite the fact that this work included all the available HIV-1 subtype B sequences gener-
ated for resistance testing during the study period and in the study area, the likely existence of
undetected and undiagnosed HIV-infected subjects prevented us from detecting all the viral
lineages that circulate in east Andalusia. In addition, this study did not take into account
migration from beyond this region because we chose to focus on the net trends throughout the
region, regardless of sporadic imports or exports. It would be most unlikely that all the subtype
B lineages of foreign origin were circulating in our region without been noticed or sampled.
We also intended to uncover the long-term well-established lineages that circulate in the
region for the first time. Future studies will be designed to uncover the relationship of the east
Andalusian HIV-1 epidemic to other regions or countries. Another aspect to consider is that
the phylogenetic cluster definition vastly varies in the literature. Most studies have used node
statistical support, genetic distance or time depth [58]. We relied on a bootstrap value in the
ML analysis, combined with posterior probabilities in the Bayesian approach. This combina-
tion is used to maximise the probability of finding regional epidemiologically relevant phylo-
genetic lineages.
Several European cohorts have described the recent emergence of HIV-1 clusters, mainly
among young MSMs [59–61]. In Spain, Yebra et al [62] reported a higher inclusion of MSMs
into transmission clusters, and Cuevas et al [63] described a higher proportion of MSM clus-
tering in the Basque country, with an important cluster that included 12 patients with the
T215D revertant. Interestingly, an expansion of this cluster has been recently reported by Vega
et al [64], and Patiño-Galindo et al [65], who have added the origin and diversification of clus-
ters in the 1990s. These findings may contribute to explain the growth in new infections in
recent years [66,67], and stress the need to increase access to HIV testing to lower transmission
rates in high-risk populations.
In summary this is the first study of the evolutionary history of HIV-1 subtype B infection,
phylodynamics and phylogeography in east Andalusia. We detected long-term lineages among
high-risk populations. We present data that are extremely important to help develop preven-
tive strategies in our scenario. We also showed how phylodynamics can be used to evaluate
model occurrence of new HIV-1 outbreaks. We mapped subtype B HIV-1 migration in east
Andalusia. Both phylogeographic and phylodynamic contributions should be considered
when healthcare managers develop appropriate prevention strategies.
Supporting Information
S1 Fig. Maximum likelihood tree of the sequences included in the detected east Andalusian
lineages (n = 234), together with the most closely related HIV-1 sequences from GenBank.
Tip labels are depicted in blue for the east Andalusian sequences (and indicate the sampling
date and region) and in black for the GenBank sequences (and indicate subtype, country,
accession number and sampling date). Lineages are highlighted.
(EPS)
S2 Fig. Prevalence of HIV-1 infected patients in Eastern Andalusian cities (Spanish vs for-
eign). Prevalence based on all patients with nationality data available (n = 453).
(EPS)
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